Skip to content

Search Results

No Matching Results

    Recently Viewed

      Listening...

      HomeLatest newsJohnson & Johnson earns a spot on Fortune‘s 2021 Change the World list.
      JNJ-Earns-Spot-on-Fortunes-2021-Change-the-World-List-lede-B.jpg

      Johnson & Johnson earns a spot on Fortune‘s 2021 Change the World list.

      The company is honored to be recognized for its part in helping battle the COVID-19 pandemic.

      Share Article
      share to

      This week Fortune included Johnson & Johnson on its 2021 Change the World list, which spotlights companies across the globe that have leveraged their core business strategies to drive positive social impact.

      While the vaccine makers on last year’s list were recognized for their unprecedented collaboration on fighting the coronavirus, this year’s list highlights those that are helping expand access to COVID-19 vaccines around the world. Johnson & Johnson is honored to be included for its efforts to make available its Janssen COVID-19 vaccine, for which it received Emergency Use Authorization from the U.S. Food and Drug Administration in February.

      To compile the prestigious list, Fortune evaluated companies on the impact they’ve made in addressing one or more of society’s problems, the business results of those actions and the level of innovation involved. Also taken into consideration: how essential the company’s initiative was to its overall business strategy.

      A commitment to social responsibility and innovation

      For more than a century, Johnson & Johnson has relied on a core set of values to guide every aspect of the way it does business.

      When COVID-19 hit, the company was able to respond to the once-in-a-lifetime global health challenge by harnessing its capabilities, scientific expertise, global partnerships and experience in helping fight pandemics for over a century—and its 130,000-plus employees around the world mobilized with urgency to address the critical needs of families, communities and healthcare providers.

      That sort of innovation and a commitment to social responsibility provide the foundation for Our Credo, the company mission statement that compels everyone who works at Johnson & Johnson to put the needs and well-being of people who depend on its products and services first.

      This isn’t the first time Fortune has recognized Johnson & Johnson. Earlier this month, Jennifer Taubert, the company’s Executive Vice President and Worldwide Chairman, Pharmaceuticals, was named to Fortune’s 2021 list of the Most Powerful Women in Business for the sixth consecutive year. In June, the company landed the #4 spot on Fortune’s Return on Leadership List, a ranking of the top 100 companies on the Fortune 500 list. And early this year, the brand included Johnson & Johnson among the World’s Most Admired Companies, placing it at #1 in the Pharmaceutical category worldwide for the eighth consecutive year.

      Johnson & Johnson is proud to be recognized again.

      More from Johnson & Johnson

      Meet a nurse who leads clinical trials to find innovative cancer therapies

      Melissa Martinez is a clinical scientist within Johnson & Johnson’s Interventional Oncology R&D group. Not only is she helping to develop lifesaving treatments, she’s redefining what it means to pursue a career in nursing.

      What’s the difference between IBS and IBD?

      These GI conditions sound similar, and they also share some symptoms. But IBS and IBD are distinct disorders—especially when it comes to treatment and the risk of complications.

      What is IL-23?

      This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat autoimmune conditions such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.